Impact Biomedical (IBO) Shares Outstanding (2022 - 2026)

Impact Biomedical's Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $107.8 million for Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 792.16% year-over-year to $107.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $107.8 million (up 792.16% YoY) and the FY2025 annual result came in at $31.6 million, up 174.26% from the prior year.
• Shares Outstanding (Entity) was $107.8 million for Q1 2026 at Impact Biomedical, up from $31.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $107.8 million in Q1 2026 and bottomed at $10.0 million in Q2 2024.
• A 5-year average of $47.7 million and a median of $65.4 million in 2022 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) slumped 85.82% — and 2026, when it soared 792.16%.
• Impact Biomedical's Shares Outstanding (Entity) stood at $70.5 million in 2022, then slipped by 14.53% to $60.2 million in 2023, then sank by 80.91% to $11.5 million in 2024, then surged by 174.26% to $31.6 million in 2025, then soared by 241.74% to $107.8 million in 2026.
• Business Quant data shows IBO's Shares Outstanding (Entity) at $107.8 million in Q1 2026, $31.6 million in Q4 2025, and $12.2 million in Q3 2025.